Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

China flag China · Delayed Price · Currency is CNY
6.99
-0.02 (-0.29%)
Apr 30, 2026, 3:04 PM CST
24.60%
Market Cap 3.52B
Revenue (ttm) 1.05B
Net Income (ttm) 172.02M
Shares Out 503.20M
EPS (ttm) 0.34
PE Ratio 20.44
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,033,710
Average Volume 15,293,548
Open 6.41
Previous Close 7.01
Day's Range 6.41 - 7.11
52-Week Range 5.53 - 8.60
Beta 0.39
RSI 57.53
Earnings Date Apr 28, 2026

About SHE:002412

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China. [Read more]

Sector Healthcare
Founded 1998
Employees 1,675
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002412
Full Company Profile

Financial Performance

In 2024, SHE:002412's revenue was 1.00 billion, an increase of 5.12% compared to the previous year's 955.53 million. Earnings were 220.24 million, an increase of 7.43%.

Financial Statements

News

There is no news available yet.